Business Description
Active Biotech AB
ISIN : SE0001137985
Description
Active Biotech AB focuses on the research and development of pharmaceuticals products within medical areas including neurodegenerative diseases, autoimmune/inflammatory disease and various forms of cancer. Its project portfolio contains both small molecules that are orally active immunomodulatory agents and antibody based immunotherapy.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.36 | |||||
| Equity-to-Asset | 0.09 | |||||
| Debt-to-Equity | 3.25 | |||||
| Debt-to-EBITDA | -0.11 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -0.9 | |||||
| 3-Year EPS without NRI Growth Rate | -1.3 | |||||
| 3-Year FCF Growth Rate | -0.9 | |||||
| 3-Year Book Growth Rate | -13.6 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.93 | |||||
| Quick Ratio | 0.93 | |||||
| Cash Ratio | 0.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29 | |||||
| Shareholder Yield % | 0.52 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -329.81 | |||||
| ROA % | -161.31 | |||||
| ROIC % | -287.09 | |||||
| ROC (Joel Greenblatt) % | -968.01 | |||||
| ROCE % | -271.11 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 134.5 | |||||
| EV-to-EBIT | -6.15 | |||||
| EV-to-EBITDA | -6.15 | |||||
| EV-to-FCF | -6.45 | |||||
| Earnings Yield (Greenblatt) % | -16.26 | |||||
| FCF Yield % | -13.8 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Active Biotech AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.053 | ||
| Beta | 0.29 | ||
| Volatility % | 22.87 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR (kr) | 0 | ||
| 20-Day SMA (kr) | 0.37117 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (kr) | 0.37117 - 0.371173 | ||
| Shares Outstanding (Mil) | 1,065.53 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Active Biotech AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Active Biotech AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Active Biotech AB Frequently Asked Questions
What is Active Biotech AB(LTS:0GQU)'s stock price today?
The current price of LTS:0GQU is kr0.37. The 52 week high of LTS:0GQU is kr0.37 and 52 week low is kr0.37.
When is next earnings date of Active Biotech AB(LTS:0GQU)?
The next earnings date of Active Biotech AB(LTS:0GQU) is 2025-02-07 Est..
Does Active Biotech AB(LTS:0GQU) pay dividends? If so, how much?
Active Biotech AB(LTS:0GQU) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers